These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16686775)

  • 41. Assessment of exhaled breath condensate pH in exacerbations of asthma and chronic obstructive pulmonary disease: A longitudinal study.
    Antus B; Barta I; Kullmann T; Lazar Z; Valyon M; Horvath I; Csiszer E
    Am J Respir Crit Care Med; 2010 Dec; 182(12):1492-7. PubMed ID: 20656939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The common rejection module in chronic rejection post lung transplantation.
    Sacreas A; Yang JYC; Vanaudenaerde BM; Sigdel TK; Liberto JM; Damm I; Verleden GM; Vos R; Verleden SE; Sarwal MM
    PLoS One; 2018; 13(10):e0205107. PubMed ID: 30289917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Persistent high BAL fluid granulocyte activation marker levels as early indicators of bronchiolitis obliterans after lung transplant.
    Riise GC; Andersson BA; Kjellström C; Martensson G; Nilsson FN; Ryd W; Scherstén H
    Eur Respir J; 1999 Nov; 14(5):1123-30. PubMed ID: 10596701
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns and significance of exhaled-breath biomarkers in lung transplant recipients with acute allograft rejection.
    Studer SM; Orens JB; Rosas I; Krishnan JA; Cope KA; Yang S; Conte JV; Becker PB; Risby TH
    J Heart Lung Transplant; 2001 Nov; 20(11):1158-66. PubMed ID: 11704475
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
    Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
    J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Donor-Derived Exosomes With Lung Self-Antigens in Human Lung Allograft Rejection.
    Gunasekaran M; Xu Z; Nayak DK; Sharma M; Hachem R; Walia R; Bremner RM; Smith MA; Mohanakumar T
    Am J Transplant; 2017 Feb; 17(2):474-484. PubMed ID: 27278097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of Circulating MicroRNAs in the Immunopathogenesis of Rejection After Pediatric Lung Transplantation.
    Xu Z; Yang W; Steward N; Sweet SC; Danziger-Isakov L; Heeger PS; Mohanakumar T
    Transplantation; 2017 Oct; 101(10):2461-2468. PubMed ID: 27941431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo.
    Nair RV; Huang X; Shorthouse R; Adams B; Brazelton T; Braun-Dullaeus R; Morris RE
    Transplant Proc; 1997; 29(1-2):614-5. PubMed ID: 9123154
    [No Abstract]   [Full Text] [Related]  

  • 49. Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung.
    Riise GC; Williams A; Kjellström C; Schersten H; Andersson BA; Kelly FJ
    Eur Respir J; 1998 Jul; 12(1):82-8. PubMed ID: 9701419
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis.
    Gottlieb J; Mattner F; Weissbrodt H; Dierich M; Fuehner T; Strueber M; Simon A; Welte T
    Respir Med; 2009 May; 103(5):743-9. PubMed ID: 19117741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pre-transplant impedance measures of reflux are associated with early allograft injury after lung transplantation.
    Lo WK; Burakoff R; Goldberg HJ; Feldman N; Chan WW
    J Heart Lung Transplant; 2015 Jan; 34(1):26-35. PubMed ID: 25444368
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exhaled nitric oxide in human lung transplantation. A noninvasive marker of acute rejection.
    Silkoff PE; Caramori M; Tremblay L; McClean P; Chaparro C; Kesten S; Hutcheon M; Slutsky AS; Zamel N; Keshavjee S
    Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1822-8. PubMed ID: 9620912
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of defensins in the pathogenesis of chronic lung allograft rejection.
    Tiriveedhi V; Banan B; Deepti S; Nataraju A; Hachem R; Trulock E; Alexander PG; Thalachallour M
    Hum Immunol; 2014 Apr; 75(4):370-7. PubMed ID: 24380698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased levels of endothelin-1 in bronchoalveolar lavage fluid of patients with lung allografts.
    Scherstén H; Hedner T; McGregor CG; Miller VM; Mårtensson G; Riise GC; Nilsson FN
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):253-8. PubMed ID: 8551773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Telemetric system for ambulatory lung function analysis in transplanted patients.
    Ewert R; Wensel R; Müller J; Hetzer R
    Transplant Proc; 2000 Feb; 32(1):204-5. PubMed ID: 10701025
    [No Abstract]   [Full Text] [Related]  

  • 56. Involvement of IL-26 in bronchiolitis obliterans syndrome but not in acute rejection after lung transplantation.
    Magnusson JM; Ericson P; Tengvall S; Stockfelt M; Brundin B; Lindén A; Riise GC
    Respir Res; 2022 May; 23(1):108. PubMed ID: 35501858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differences of airway dimensions between patients with and without bronchiolitis obliterans syndrome after lung transplantation-Computer-assisted quantification of computed tomography.
    Doellinger F; Weinheimer O; Zwiener I; Mayer E; Buhl R; Fahlenkamp UL; Dueber C; Achenbach T
    Eur J Radiol; 2016 Aug; 85(8):1414-20. PubMed ID: 27423681
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Self-reactive antibodies associated with bronchiolitis obliterans syndrome subtype of chronic lung allograft dysfunction.
    Kaza V; Zhu C; Terada LS; Wang L; Torres F; Bollineni S; Mohanka M; Banga A; Joerns J; Mohanakumar T; Li QZ
    Hum Immunol; 2021 Jan; 82(1):25-35. PubMed ID: 33129576
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bronchoalveolar lavage neutrophilia in acute lung allograft rejection and lymphocytic bronchiolitis.
    Vos R; Vanaudenaerde BM; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Van Raemdonck DE; Dupont LJ; Nawrot TS; Verbeken EK; Verleden GM
    J Heart Lung Transplant; 2010 Nov; 29(11):1259-69. PubMed ID: 20673640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytological monitoring of peripheral blood, bronchoalveolar lavage fluid, and transbronchial biopsy specimens during acute rejection and cytomegalovirus infection in lung and heart--lung allograft recipients.
    Tikkanen J; Lemström K; Halme M; Pakkala S; Taskinen E; Koskinen P
    Clin Transplant; 2001 Apr; 15(2):77-88. PubMed ID: 11264632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.